AKP-11

N/A

Report date: 2022/01/14 13:23:58

NME

Base Information

Drug NameAKP-11

Drug Alias NameAKP-11

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionInsulin receptor agonistsProtein kinase AMP-activated non-catalytic subunit beta 1 activatorsProtein tyrosine phosphatase inhibitors +[4]

TargetsProtein kinase AMP-activated non-catalytic subunit beta 1Protein tyrosine phosphataseInsulin receptor +[4]

Therapy Area/IndicationsPsoriasisDermatitis, Atopic

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryAustralia

CombinationsNo

Global Highest StatusPhase 2 Clinical

Highest Status in ChinaN/A

Originator CompaniesAkaal Pharma

China Registration ClassN/A

Develop Information

Active CompaniesAkaal Pharma

Inactive CompaniesN/A

Active IndicationsPsoriasisDermatitis, Atopic

Inactive IndicationsN/A

Other Information

ATC CodeN/A